Skip to Main Content

Paper Details

Cystatin C is associated with adverse COVID-19 outcomes in diverse populations.
iScience
3
2022
Author NameAffiliation
James F WilsonMRC Institute of Genetics and Cancer, University of Edinburgh
James F WilsonUsher Institute, University of Edinburgh
Markus RalserCharite - Universitatsmedizin Berlin
Krzysztof KirylukVagelos College of Physicians & Surgeons, Columbia University
Krzysztof KirylukVagelos College of Physicians & Surgeons, Columbia University
Andrea GannaInstitute for Molecular Medicine Finland, University of Helsinki
Andrea GannaMassachusetts General Hospital
Andrea GannaInstitute for Molecular Medicine Finland, University of Helsinki
Andrea GannaMassachusetts General Hospital
John Kenneth BaillieMRC Institute of Genetics and Cancer, University of Edinburgh
  • 1 - 10

Datasets

Release 1.2